Benzenesulfonamide compounds and their use as therapeutic agents

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9630929
APP PUB NO 20140296245A1
SERIAL NO

14355552

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention is directed to benzensulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of sodium channel-mediated diseases or conditions, such as pain.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
XENON PHARMACEUTICALS INC200 - 3650 GILMORE WAY BURNABY B C V5G 4W8

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chafeev, Mikhail Burnaby, CA 39 629
Jia, Qi Burnaby, CA 129 1193
Oballa, Renata Marcella Burnaby, CA 13 75
Sun, Shaoyi Burnaby, CA 71 908
Zenova, Alla Yurevna Burnaby, CA 30 309
Zhang, Zaihui Burnaby, CA 67 611

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 25, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00